The diagnosis and treatment of celiac disease;Diagnostik und therapie der zöliakie

Deutsches Arzteblatt International

Volumn 110, Issue 49, 2013, Pages

  Schuppan, Detlef ^a,b,c   Zimmer, Klaus Peter ^d  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER; TISSUE TRANSGLUTAMINASE 2, HUMAN;

ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIFFERENTIAL DIAGNOSIS; HUMAN; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE INFECTION; MALABSORPTION; BLOOD; EVIDENCE BASED MEDICINE; GLUTEN FREE DIET; INTERNATIONAL COOPERATION; PRACTICE GUIDELINE; PROCEDURES; STANDARDS;

BIOLOGICAL MARKERS; CELIAC DISEASE; DIET, GLUTEN-FREE; EVIDENCE-BASED MEDICINE; HUMANS; INTERNATIONALITY; PRACTICE GUIDELINES AS TOPIC; TRANSGLUTAMINASES;

EID: 84893057732     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0835     Document Type: Article

References (40)

1. Dieterich W, Ehnis T, Bauer M., et al.: Identification of tissue trans-glutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
2. Mustalahti K, Catassi C, Reunanen A., et al.: The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med 2010; 42: 587-95.
3. Rostom A, Dube C, Cranney A., et al.: Celiac Disease. Evidence Report/ Technology Assessment No. 104. Rockville (MD): Agency for Healthcare Research and Quality (US); 2004.
4. Hill ID, Dirks MH, Liptak G.S., et al.: Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Journal of Pediatric Gastroenterology and Nutrition 2005; 40: 1-19.
5. Rostom A, Murray JA, Kagnoff MF: American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1981-2002.
6. (UK) CfCPaN: Coeliac disease: recognition and assessment of coeliac disease. London: National Institute for Health and Clinical Excellence (UK) 2009.
7. Husby S, Koletzko S, Korponay-Szabo IR, et al.: European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. Journal of Pediatric Gastroenterology and Nutrition 2012; 54: 136-60.
8. Schuppan D, Junker Y, Barisani D: Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009; 137: 1912-33.
9. Zimmer K.P., Fischer I, Mothes T., et al.: Endocytotic segregation of gliadin peptide 31-49 in enterocytes. Gut 2010; 59: 300-10.
10. Junker Y, Zeissig S, Kim S.J., et al.: Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4. The Journal of Experimental Medicine 2012; 209: 2395-408.
11. Reilly NR, Green PH: Epidemiology and clinical presentations of celiac disease. Seminars in immunopathology 2012; 34: 473-8.
12. Barada K, Abu Daya H, Rostami K, Catassi C: Celiac disease in the developing world. Gastrointestinal endoscopy clinics of North America 2012; 22: 773-96.
13. Henker J, Losel A, Conrad K., Hirsch T, Leupold W: Prävalenz der asymptomatischen Zöliakie bei Kindern und Erwachsenen in der Region Dresden. [Prevalence of asymptommatic coeliac disease in children and adults in the Dresden region of Germany]. Deutsche Medizinische Wochenschrift 2002; 127: 1511-5.
14. Croese J, Gaze ST, Loukas A: Changed gluten immunity in celiac disease by Necator americanus provides new insights into autoimmunity. International Journal for Parasitology 2013; 43: 275-82.
15. Stene LC, Honeyman MC, Hoffenberg E.J., et al.: Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study. The American Journal of Gastroenterology 2006; 101: 2333-40.
16. Zimmer KP: Klinische Bedeutung nichtklassischer Zöliakieformen. Dt Ärztebl 2001; 98: A3285-3292 [Heft 49].
17. Ventura A, Magazzu G, Greco L: Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 1999; 117: 297-303.
18. Dittmar M, Kahaly GJ: Genetics of the autoimmune polyglandular syndrome type 3 variant. Thyroid: Official Journal of the American Thyroid Association 2010; 20: 737-43.
19. Roshan B, Leffler DA, Jamma S, et al: The incidence and clinical spectrum of refractory celiac disease in a north american referral center. The American Journal of Gastroenterology 2011; 106: 923-8.
20. Rubio-Tapia A., Murray JA: Classification and management of refractory coeliac disease. Gut 2010; 59: 547-57.
21. Malamut G, Meresse B, Cellier C., Cerf-Bensussan N: Refractory celiac disease: from bench to bedside. Seminars in immunopathology 2012; 34: 601-13.
22. Leffler DA, Schuppan D: Update on serologic testing in celiac disease. The American Journal of Gastroenterology 2010; 105: 2520-4.
23. Simell S, Hoppu S, Hekkala A., et al.: Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. The American Journal of Gastroenterology 2007; 102: 2026-35.
24. Richter T, Bossuyt X, Vermeersch P., et al.: Determination of IgG and IgA antibodies against native gliadin is not helpful for the diagnosis of coeliac disease in children up to 2 years old. Journal of Pediatric Gastroenterology and Nutrition 2012; 55: 21-5.
25. Oberhuber G, Caspary W F, Kirchner T, Borchard F., Stolte M, German Society for Pathology Task Force on Gastroenterologic P: Empfehlungen zur Zöliakie-/Spruediagnostik (Arbeitsgemeinschaft für gastroenterologische Pathologie der Deutschen Gesellschaft für Pathologie). [Diagnosis of celiac disease and sprue. Recommendations of the German Society for Pathology Task Force on Gastroenterologic Pathology]. Der Pathologe 2001; 22: 72-81.
26. Chang F, Mahadeva U, Deere H: Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. A PMIS 2005; 113: 385-99.
27. Dahlbom I, Korponay-Szabo IR, Kovacs J.B., Szalai Z., Maki M, Hansson T: Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. Journal of Pediatric Gastroenterology and Nutrition 2010; 50: 140-6.
28. Leffler D, Schuppan D, Pallav K., et al.: Kinetics of the histological, sero-logical and symptomatic responses to gluten challenge in adults with coeliac disease. Gut 2012.
29. Zimmer KP: Nutrition and celiac disease. Current problems in pediatric and adolescent health care 2011; 41: 244-7.
30. Elfstrom P, Granath F, Ekstrom Smedby K, et al: Risk of lympho-proliferative malignancy in relation to small intestinal histopathology among patients with celiac disease. Journal of the National Cancer Institute 2011; 103: 436-44.
31. Hansen D, Brock-Jacobsen B, Lund E., et al.: Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes care 2006; 29: 2452-6.
32. Khashan AS, Henriksen TB, Mortensen P.B., et al.: The impact of maternal celiac disease on birthweight and preterm birth: A Danish population-based cohort study. Hum Reprod 2010; 25: 528-34.
33. Mukherjee R, Kelly C P, Schuppan D: Nondietary therapies for celiac disease. Gastrointestinal endoscopy clinics of North America 2012; 22: 811-31.
34. Norris JM, Barriga K, Hoffenberg E.J., et al.: Risk of celiac disease auto-immunity and timing of gluten introduction in the diet of infants at increased risk of disease. JAMA 2005; 293: 2343-51.
35. Ivarsson A, Persson LA, Nystrom L, et al: Epidemic of coeliac disease in Swedish children. Acta Paediatr 2000; 89: 165-71.
36. Hummel S, Pfluger M, Hummel M., Bonifacio E, Ziegler AG: Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for Type 1 Diabetes: The BABYDIET study. Diabetes care 2011.
37. Bianchi ML, Bardella MT: Bone in celiac disease. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2008; 19: 1705-16.
38. Kane EV, Newton R, Roman E: Non-Hodgkin lymphoma and gluten-sensitive enteropathy: estimate of risk using meta-analyses. Cancer Causes Control 2011.
39. Metzger MH, Heier M, Maki M., et al.: Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. European Journal of Epidemiology 2006; 21: 359-65.
40. Rubio-Tapia A., Kyle RA, Kaplan E.L., et al.: Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology 2009; 137: 88-93.